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GLIS1 regulates trabecular meshwork function and
intraocular pressure and is associated with
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Chronically elevated intraocular pressure (IOP) is the major risk factor of primary open-angle
glaucoma, a leading cause of blindness. Dysfunction of the trabecular meshwork (TM), which
controls the outflow of aqueous humor (AqH) from the anterior chamber, is the major cause
of elevated IOP. Here, we demonstrate that mice deficient in the Krüppel-like zinc finger
transcriptional factor GLI-similar-1 (GLIS1) develop chronically elevated IOP. Magnetic
resonance imaging and histopathological analysis reveal that deficiency in GLIS1 expression
induces progressive degeneration of the TM, leading to inefficient AqH drainage from the
anterior chamber and elevated IOP. Transcriptome and cistrome analyses identified several
glaucoma- and extracellular matrix-associated genes as direct transcriptional targets of GLIS1.
We also identified a significant association between GLIS1 variant rs941125 and glaucoma in
humans (P = 4.73 × 10−6), further supporting a role for GLIS1 into glaucoma etiology. Our
study identifies GLIS1 as a critical regulator of TM function and maintenance, AqH dynamics,
and IOP.
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A glaucoma is a heterogeneous group of progressive opticneuropathies characterized by the degeneration of theoptic nerve that results in irreversible blindness1. Primary
open-angle glaucoma (POAG) and primary angle-closure glau-
coma (PACG) are the two most common forms of glaucoma in
adults2–5, while primary congenital glaucoma accounts for up to
18% of childhood blindness6. Age, ethnicity, gender, environ-
mental, and genetic factors all contribute to glaucoma
susceptibility7–9. However, elevated intraocular pressure (IOP) is
the major causal risk factor for glaucoma.
Normal IOP is required to maintain the proper physiological
function of the eye and also to maintain the structure of the globe
of the eye. The maintenance of homeostatic IOP is critically
dependent on the balance between the inflow and outflow of
aqueous humor (AqH)10. AqH is secreted by the ciliary body into
the ocular anterior chamber (AC) where it nourishes avascular
tissues. The AqH subsequently exits through specialized drainage
structures located at the junction where the iris meets the cornea
(iridocorneal angle). The ocular drainage structures are primarily
composed of the trabecular meshwork (TM) and Schlemm’s canal
(SC). AqH first flows through the TM into the SC and subse-
quently enters the episcleral veins before returning back to the
systemic circulation10–12. TM dysfunction has been causally
linked to impaired AqH drainage (increased outflow resistance)
and elevated IOP10,13–15.
An increasing number of rare mutations and common genetic
variants in a variety of genes, including MYOC, CYP1B1, GLIS3,
LOXL4, LTBP2, PITX2, and OPTN, have been associated with
elevated IOP and different types of glaucoma4,5,9,16–24.
GLI-Similar 1 (GLIS1), together with GLIS2 and −3, comprise
a subfamily of Krüppel-like zinc finger (ZF) transcriptional
factors25–27. In contrast to GLIS2 and GLIS3, relatively little is
known about the physiological functions of GLIS1. To obtain
greater insights into the biological roles of GLIS1, we analyzed
Glis1-KO mice for phenotypic alterations and found that these
mice develop an enlarged eye phenotype.
In this study, we examine the function of GLIS1 in ocular
tissues in more detail and demonstrate that GLIS1 plays a critical
regulatory role in maintaining normal TM structure and IOP. We
show that GLIS1 is expressed in the TM, a tissue critical in the
regulation of outflow resistance. Deficiency in GLIS1 induces
progressive degeneration of the TM, leading to inefficient AqH
drainage and elevated IOP. To obtain insights into potential
mechanisms that may underlie this phenotype, changes in the
expression of target genes were examined. Combined RNA-Seq
and ChIP-Seq analyses identified a number of genes that are
directly regulated by GLIS1, including MYOC, CYP1B1, LOXL4,
and LTBP2, genes previously implicated in glaucoma6,28.
Importantly, we have detected significant associations between
common genetic variants in the GLIS1 region and POAG in
humans, thereby supporting the role of GLIS1 as a glaucoma risk
gene. These variants may impact TM functions and compromise
AqH drainage thereby contributing to elevated IOP and
glaucoma.
Results
Identification of GLIS1 physiological functions. To obtain
insights into the physiological functions of GLIS129,30, Glis1-KO
mice were examined for any potential phenotypic alterations. In
these mice, most of exon 4 (840 bp) was replaced by lacZ con-
taining three Stop codons (lacZ-Stop3) generating a fusion pro-
tein (GLIS1N-βGal) consisting of the N-terminus of GLIS1 and β-
galactosidase (β-Gal). This protein lacks the entire DNA-binding
domain (DBD) and C-terminus of GLIS1, including its transac-
tivation domain (TAD) (Supplementary Fig. 1a). The fusion
protein was undetectable by immunohistochemical staining for β-
Gal (1:1000, PR-Z3781, Promega) in several tissues suggesting
that it may be proteolytically degraded. Reporter transactivation
analysis demonstrated that mutations in the ZF motifs that
abolish their tetrahedral configuration, and deletion of the
C-terminal TAD greatly decreased or fully abolished GLIS1
transcriptional activity (Supplementary Fig. 1b). These data
indicate that loss of the ZFs and TAD in Glis1-KO mice abolishes
the ability of GLIS1 to recognize the GLIS binding site (GLISBS)
and to regulate the transcription of target genes. Supporting the
specificity of the Glis1-KO, deletion of exon 4 had no significant
effect on the expression of Dmrtb1, Slc1a7, Dio1, and Cpt2, genes
neighboring Glis1, nor the expression of Glis2 and Glis3 in Glis1-
KO kidneys and testes (Supplementary Fig. 1c, d).
Evaluation of 1–6 months C57BL/6NCrl Glis1-KO mice
revealed that these mice developed enlarged eyes (Fig. 1a), while
no other obvious abnormalities were observed. Similarly, no eye
enlargement was observed in 129S6/SvEvTac Glis1-KO mice.
Male and female KO mice in both backgrounds noticeably
developed this abnormal eye phenotype between 2 and 3 months
of age, which became more pronounced with age. Because
protruding eyes are well-established comorbidity commonly
associated with Graves’ disease, an autoimmune disease leading
to hyperthyroidism31, and since GLIS1 and GLIS3 family
members have been implicated in several thyroid gland-
associated diseases25,27,32,33, we examined whether this Glis1-
KO phenotype was related to the development of Graves’ disease
that is characterized by high circulating levels of T3/T4 and low
TSH. However, our analysis of serum T3, T4, and TSH showed
that their levels were not significantly different between WT and
Glis1-KO C57BL/6NCrl mice indicating that this phenotype was
not related to the development of Graves’ disease (Supplementary
Fig. 2).
IOP is elevated in Glis1-KO mice. To examine whether the
enlarged eye phenotype was associated with anatomic changes in
intra- and periocular tissues, we performed Gadolinium magnetic
resonance imaging (Gd-MRI) on the formalin-fixed specimens
from 2.5-month-old WT and Glis1-KO C57BL/6NCrl mice. The
contrast agent Gd has been used to assess ocular anatomy by
MRI34,35. Analysis of multiple MRI images through the head
revealed that there was little difference between the size of the
periocular tissues in Glis1-KO relative to WT littermates in all
three orientations. Importantly, we consistently observed an
enlargement of the AC in both the right and left eyes of the Glis1-
KO mice (Fig. 1a). The enlargement of AC observed in the Glis1-
KO mice might be due to defective AqH drainage causing
increased AqH accumulation that leads to the observed
elevated IOP.
To obtain further support for this hypothesis, we measured
IOP in WT and Glis1-KO mice over a 12-month time period. Our
data demonstrated that IOP is significantly elevated in male as
well as female Glis1-KO mice relative to age and gender-matched
WT littermates (Fig. 1b, c). An increase in IOP was observed as
early as in 1-month-old mice and then steadily increased before
plateauing at 8 months. Further analysis revealed that the
progressive, age-dependent increase in IOP was similar between
left and right eyes (Supplementary Fig. 3). Together, these
observations suggested a role for GLIS1 in the regulation of IOP.
Decreased AqH outflow in eyes from GLIS1-deficient mice.
Elevated IOP is most commonly caused by outflow resistance. To
determine whether the elevated IOP in Glis1-KO C57BL/6NCrl
mice was due to changes in AqH drainage, we employed dynamic
contrast-enhanced MRI to evaluate AqH dynamics in vivo. The
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contrast agent Gd present in the AC enhances the T1-weighted
MRI signal brightness and serves as a tracer, thereby providing a
readout for AqH accumulation and outflow34,35. Following
administration of Gd, 2 months-old mice were scanned for 2 h at
10min intervals and Gd accumulation in the AC was measured
relative to the initial baseline (see image source files at https://
civmvoxport.vm.duke.edu/voxbase/studyhome.php?studyid=733).
Our data indicated that in WT mice Gd is readily cleared from the
eye (Fig. 1d). A significant (29%; p < 0.0001) increase in Gd
accumulation in the AC was detected in Glis1-KO eyes as com-
pared to the WT eyes suggesting impaired AqH exit. It is well-
established that a major route of AqH exit from the AC is via the
conventional drainage pathway comprising the TM and SC10. To
obtain further support for this hypothesis, we evaluated the AqH
dynamics in Glis1-KO mice following topical administration (5 μl,
0.4%) of Ripasudil. This drug functions as an IOP lowering Rho-
kinase inhibitor that enhances AqH outflow via the TM and SC36.
As shown in Fig. 1d, Ripasudil treatment significantly reduced Gd
accumulation in the ocular AC of Glis1-KO mice as compared to
treatment with isotonic saline in the contralateral eye consistent
with its IOP lowering effects. Our data suggest that the increased
IOP observed in the Glis1-KO mice correlates with reduced AqH
outflow and might involve dysfunction of the TM, a major cause
of elevated IOP and glaucoma.
Progressive disruption of ocular drainage structures in Glis1-
KO mice. To determine whether structural and morphological
changes of ocular drainage tissues in Glis1-KO mice might
underlie TM dysfunction and elevated IOP, we performed a
detailed ocular histological examination of WT, Glis1-hetero-
zygous and Glis1-KO mice maintained in a C57BL/6NCrl strain.
Ocular angle structures of the Glis1-heterozygous mice showed an
intact ocular drainage tissue, unlike the Glis1-KO that exhibited
TM degeneration (Supplementary Fig. 4a, b). This lack of phe-
notype in heterozygous mice is consistent with that these mice
did not develop elevated IOP (Supplementary Fig. 4c). Histolo-
gical analyses demonstrated that the angle structures of the Glis1-
KO eyes initially appear normal. At 3 weeks, no significant
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Fig. 1 Anterior chamber is enlarged, IOP elevated, and AqH dynamics altered in Glis1-KO mice. a Representative MRI images from 2.5-month-old WT
and Glis1-KO mice showing the increased size of the anterior chamber in Glis1-KO mice compared to WT. The upper two images are in vivo images
acquired by dynamic contrast enhancement in the eye. The lower four images are coronal and sagittal sections of eyes from fixed specimen stained with
gadolinium using active staining. The anterior chamber is outlined by the dotted line. Scale bar= 2mm. b, c Comparison of IOP levels in male (b) and
female (c) WT (squares) and Glis1-KO (circles) mice as a function of age. Male mice examined: at 1 and 2 months (n= 3); 3 (n= 5); 4 and 7 (n= 8); 5
(n= 6); 6, 11, and 12 months (n= 7). For female mice: 1 and 2 months (n= 10); 3–7, 9, and 10 months (n= 4); 8 (n= 5); 11 and 12 months (n= 3). IOP data
from left and right eyes were combined and 4 IOP measurements/eye/time points were performed; thus, a total of 24–80 measurements at each time
point. Data are represented as means ± SD. Statistical analyses were performed with a two-tailed Student’s t test. *p < 10−5. The dotted line indicates basal
IOP level in 1–3-month-old mice. d AqH dynamics was examined by Gd-enhanced MRI over a 2 h period. Percent of Gd signal enhancement was
determined and plotted. Left eye of 2-month-old WT mice (n= 3; black line) and Glis1-KO mice (n= 4; red line) was treated topically with saline and the
right eye of Glis1-KO mice with Ripasudil (0.04%) (n= 4; blue line). Data are represented as means ± SD). Statistical analyses were performed with a two-
tailed Student’s t test. *p < 10−2; **p < 10−3; ***p < 10−4.
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difference in TM morphology was observed suggesting that
GLIS1 has no major effect on TM development (Fig. 2a, b;
Supplementary Fig. 5). Major phenotypic changes are observed by
6–8 weeks of age (Fig. 2c–f). Focal regions of the angles in
6-week-old Glis1-KO mice exhibited thinning of the TM (hypo-
plasia) in a substantial proportion of mutant eyes (Fig. 2d; Sup-
plementary Fig. 6), while some local regions lacked discernible
TM. Based on histology, the damage to the ocular drainage
structure within an eye is quite variable at earlier time points
(6 weeks) with some regions appearing much more normal. Such
local variability is well documented for other glaucoma genes and
may partially explain the relatively modest increase in IOP37,38.
The loss of GLIS1 function did not affect the gross morphology
of the SC at an early time point (4 weeks) (Supplementary Fig. 7a,
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b) when the TM is still largely intact. However, at later ages
(6 weeks and older), but more common at 3 months and older
ages, there are regions where the SC becomes partially or
completely collapsed (Fig. 2e, f). This might be due to a regional
or complete degeneration of the TM that may protect the SC
from collapse. At older ages (over 6 months), in addition to the
degeneration of the TM and collapse of the ocular drainage
structures, Glis1-KO eyes exhibited anterior synechiae character-
ized by a fusion of the iris and cornea causing angle closure
(Supplementary Fig. 8a). Besides the observed defects in the
ocular drainage structures, no gross abnormalities were observed
in other ocular tissues (Supplementary Figs. 7c and 8b). We also
characterized the ocular angle of Glis1-KO mice maintained in a
129S6/SvEvTac background. These mice exhibited thinning of the
TM layer like that observed in the C57BL/6NCrl background
(Supplementary Fig. 9). Our data suggest that GLIS1 deficiency
leads to progressive TM dysfunction and TM degeneration.
GLIS1 is highly expressed in TM cells. Since the TM plays a
major role in the regulation of AqH drainage and IOP, we decided to
focus our study on the analysis of the TM. To examine whether the
observed changes in the TM might be intrinsic to the loss of GLIS1
expression in this tissue, we analyzed GLIS1 expression in human
TM (HTM) tissue and primary HTM cells. The human GLIS1 gene
and its mouse orthologue can generate two transcripts, long and
short (referred to as GLIS1L and GLIS1S) that generate a 795 or a 620
amino acids protein, respectively (a 789 and 620 amino acid protein
in mice) (https://useast.ensembl.org/Homo_sapiens/Gene/Summary?
db=core;g=ENSG00000174332;r=1:53506237-53738106). QPCR
analysis demonstrated that GLIS1L was the primary transcript in
primary HTM cells, and all human tissues tested (Supplementary
Fig. 10), whereas GLIS1S was expressed at very low levels. In isolated
HTM, characterized by their high myocilin (MYOC) expression,
GLIS1 mRNA was expressed at levels comparable to that of the
kidney, a tissue in which GLIS1 is highly expressed29 (Fig. 3a). qPCR
analysis further showed that GLIS1 mRNA was highly expressed in
mouse ocular tissue enriched in the TM, moderately in the ciliary
body, and at very low levels in the cornea and retina (Fig. 3b). In situ
RNA localization by RNAscope supported the expression of Glis1
transcripts in the TM and ciliary body isolated from 3-month-old
WT mice (Fig. 3c), whereas Glis1 transcripts were not detectable in
the iris and cornea. These data indicated that GLIS1 expression is
intrinsic to TM cells and suggests that the TM dysfunction observed
in Glis1-KO mice is likely causally related to the loss of GLIS1
transcription activation function in these cells. In contrast to TM, the
ciliary body, which also expressed Glis1, exhibited a properly orga-
nized epithelial layer (Supplementary Fig. 7c).
Regulation of gene expression by GLIS1 in primary human TM
cells. GLIS1 regulates gene transcription by binding to GLISBS in
the promoter regulatory region of target genes25,26. To investigate
alterations in gene expression that might underlie the phenotypic
changes observed in TM cells, we performed RNA-Seq and ChIP-
Seq analyses. Transcriptome analysis was performed with HTM
(shGLIS1) cells, in which GLIS1 expression was knocked down by
GLIS1 shRNA lentivirus, and with control cells (HTM (Scr))
infected with scrambled shRNA lentivirus. The volcano plot in
Fig. 4a shows the distribution of downregulated and upregulated
genes in HTM(shGLIS1) cells in comparison to HTM(Scr) cells.
In addition to downregulation of GLIS1 mRNA, the expression of
several genes associated with TM functions was decreased in
HTM(shGLIS1) cells, including MYOC, CHI3L1, SPARC,
CYP1B1, and APOD39–41(Fig. 4a, b; Supplementary Table 2). In
addition, the expression of a variety of genes encoding extra-
cellular matrix (ECM) components was reduced in HTM
(shGLIS1) cells, including a number of collagen genes (e.g.,
COL1A2, COL6A2, and COL4A1/2), fibulins (FBLN1 and FBLN5),
microfibril-related genes (FBN2, LOXL1-4, and LTBP2), matrix
metalloproteinases (ADAMTS10 and MMP2), and genes involved
in cell-cell and cell-ECM adhesion (e.g., ITGA3) (Fig. 4a, b;
Supplementary Table 2)42. In addition, the expression of a
number of genes was up-regulated, including EFEMP1 and RTN4.
qPCR-analysis confirmed the decrease in MYOC, BMP2, LOXL4,
APOD, LTBP2, and CYP1B1 mRNA expression in HTM
(shGLIS1) cells (Fig. 4e and Supplementary Fig. 11). Several of the
differentially expressed genes have previously been reported to
be associated with elevated IOP and/or glaucoma, including
MYOC, ADAMTS10, LTBP2, LOXL1, TGFBR3, CYP1B1, and
EFEMP15,28,43–45.
The regulation of many of these genes by GLIS1 was further
supported by gene expression analysis in TM cells overexpressing
GLIS1. For this analysis we used HTM(pIND-GLIS1) transiently
expressing Dox-inducible Flag-GLIS1-HA and TM5(pIND-
GLIS1), stably expressing a Dox-inducible Flag-GLIS1-HA. Dox
treatment greatly induced GLIS1 mRNA expression in TM5
(pIND-GLIS1) cells and accumulation of Flag-GLIS1-HA protein
in the nucleus (Fig. 4f; Supplementary Figure 12). Transcriptome
analysis showed that induction of GLIS1 expression in Dox-
treated HTM(pIND-GLIS1) and TM5(pIND-GLIS1) cells
enhanced the expression of many, but not all, of the same genes
that were down-regulated by shGLIS1 RNAs in HTM cells
(Fig. 4a, c, d; Supplementary Table 2). QRT-PCR analysis showed
that the decreased expression of MYOC, BMP2, LOXL4, APOD,
and LTBP2 in HTM(shGLIS1) correlated with increased expres-
sion in Dox-treated TM5(pIND-GLIS1) cells (Fig. 4e, f).
Similarly, the induction of CYP1B1 mRNA in HTM(pIND-
GLIS1) cells correlated with decreased expression in HTM
(shGLIS1) (Supplementary Fig. 11). As indicated above,
decreased expression in HTM(shGLIS1) did not always perfectly
correlate with increased expression in HTM(pIND-GLIS1) and/
or TM5(pIND-GLIS1) cells (Supplementary Table 2). Such
differences might, among other things, be due to variations in
the epigenome and the transcription regulatory machinery
between primary and immortalized TM cells or different
efficiencies of the shGLIS1 used. It might further relate to
Fig. 2 Disruption of the ocular angle drainage structures in Glis1-KO mice. a, c WT mice maintained in C57BL/6NCrl background showed a well-
developed SC and TM (*) at both 3 and 6 weeks of age. b Glis1-KO-C57BL/6NCrl eyes exhibit a morphologically mature ocular drainage tissue at 3 weeks
of age. The histological assessment of the ocular angle at 3 weeks of age was performed on 6 WT and 6 Glis1-KO eyes with similar results within each
group. In contrast, by 6 weeks of age Glis1-KO eyes exhibit a variable degree of focal TM degeneration, ranging from hypoplastic TM characterized by
substantial thinning of the TM (d), reduction in the size of the Schlemm’s canal, and associated TM causing a partial collapse of the ocular drainage
structures (e). f At 6 weeks of age a small proportion of mice (<10%) showed focal regions exhibiting partial or complete collapse of the ocular drainage
structures lacking TM and Schlemm’s canal. a–f A magnified version of the image in the upper panel is shown in the lower panel. Arrows show edges of the
SC. IV Iris vessel. The histological assessment of the ocular angle at 6 weeks of age was performed on 10 WT and 15 Glis1-KO eyes with similar results
within each group. Scale bar= 50 μm. Detailed measurement of the TM area was performed on 5 eyes per experimental group, shown in Supplementary
Figs. 5 and 6.
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differences in the expression levels of endogenous GLIS1 or that
of GLIS1 target genes in HTM vs. TM5 cells or variations in the
binding affinity of GLIS1 to GLISBS of target genes.
To determine which of the differentially expressed genes were
direct transcriptional targets (cistrome) of GLIS1, we performed a
ChIP-Seq analysis. Since no suitable GLIS1 antibody was available
for ChIP-Seq and it was not feasible to establish primary HTM
cells stably expressing GLIS1, hence we utilized the TM5(pIND-
GLIS1) cells. ChIP-Seq analysis to identify direct transcriptional
targets of GLIS1 showed enrichment for GLIS1 binding (Fig. 5a).
ChIP-Seq analysis identified a total of 46,947 distinct GLIS1
binding peaks in Dox-treated TM5(pIND-GLIS1) cells. About
10% of GLIS1 binding peaks were within proximal promoter
regions 1 kb upstream of the transcription start sites (TSSs),
whereas 16% were further upstream (Fig. 5b). GLIS1 binding was
most highly enriched at introns within the gene body as we
reported for GLIS332,46. Homer de novo and known motif
analyses identified a G/C-rich GLISBS-like consensus sequence as
the top motifs (Fig. 5c). This sequence was very similar to the
consensus GLISBS reported previously32,46,47, indicating that our
ChIP-Seq was successful in detecting specific GLIS1 binding
sequences. Our GLIS1 ChIP-Seq analysis identified a number of
additional motifs, including motifs for bZIP transcription factors
(e.g., ATF3, FRA1, BATF, and JUNB, members of the AP-1
complex), forkhead box (FOX) proteins48, and TEA domain
transcription factors (TEAD) that play a key role in the Hippo
pathway49. These data suggested co-localization of the GLIS1
binding consensus with motifs for other transcription factors that
have been previously implicated in the regulation of TM and
glaucoma45,50,51. These findings are consistent with the hypoth-
esis that GLIS1 regulates TM gene transcription in coordination
with other transcription factors.
Analysis of the combined RNA-Seq and ChIP-Seq data showed
that the transcription of several of the differentially expressed
genes with roles in TM, IOP, and glaucoma, were directly
regulated by GLIS1 and included MYOC, LTBP2, CHI3L1,
HMGA1, CYP1B1, and LOXL1-4 (Supplementary Table 2).
Genome browser tracks showing the location of GLIS1 peaks
associated with several glaucoma-related genes, including MYOC,
CYP1B1, and ADAMTS10, are shown in Fig. 6. Interestingly, the
GLIS1 binding peaks in the proximal promoter regions of MYOC
and CYP1B1 are located in a region near a functional AP-1
responsive element (Figs. 5c and 6)52–54. In addition, the
proximal promoter of CYP1B1 contains a G/C-rich SP1 binding
sequence, which because of its similarity to the consensus GLISBS
might function as a GLIS1 binding site. This suggests that these
promoter regions may function as a regulatory hub for several
transcription factors. Moreover, this supports our hypothesis that
the transcription of MYOC, CYP1B1, and other TM genes by
GLIS1 is regulated in coordination with other transcription
factors, including members of the AP-1 family.
KEGG pathways analysis of GLIS1 target genes down-regulated
in HTM(shGLIS1), activated in HTM(pIND-GLIS1) or TM5
(pIND-GLIS1) cells identified pathways associated with ECM,
proteoglycans, and cellular adhesion among the top pathways in
all three data sets (Supplementary Fig. 13). This is consistent with
recent bioinformatics analyses of TM gene expression data that
identified cell–matrix and cell–cell interaction-related pathways
among the top pathways involved in the pathogenesis of POAG55.
Association of GLIS1 rs941125 with glaucoma. Our study of
Glis1-KO mice identified a critical regulatory function for GLIS1
in the maintenance and function of the TM, a tissue that plays a
major role in controlling AqH outflow and the development of
glaucoma1,15,56,57. These findings raised the question of whether
GLIS1 might be involved in the pathogenesis of human glaucoma
as well. To assess this, we examined the association of SNPs in the
GLIS1 region and the risk of glaucoma, combining information
from the GERA and UKB cohorts9. rs941125, which localizes to
intron 1 of GLIS1, was the most strongly associated SNP in the
region, reaching a Bonferroni corrected level of significance (odds








































































































Fig. 3 GLIS1 is highly expressed in TM. a QPCR analysis of GLIS1 and MYOC mRNA expression in human TM tissue, kidney (Ki), and liver (Li) (n= 3;
technical replicates). Statistical analyses were performed with a two-tailed Student’s t test. Data are represented as means ± SD. p Values are indicated
above the bars. b Comparison of mouse GLIS1 RNA expression in several ocular tissues with that of kidney, a tissue in which GLIS1 is highly expressed (n=
3; distinct samples). Statistical analyses were done with a two-tailed Student’s t test. Data are represented as means ± SD. p Values are indicated above the
bars. c RNAscope in situ hybridization with eye sections from a 3-month-old WT mouse showed that GLIS1 mRNA (yellow speckles) expression was
restricted to TM and CB. Dashed lines outline different cell compartments. Kidney (Ki), Cornea (C), Retina (R), Ciliary Body (CB), Trabecular Meshwork
(TM), Corneal StromaI (CS), Iris (I), and Schlemm’s canal (SC). Scale bar= 50 μm.
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The association of rs941125 with POAG has recently been con-
firmed and replicated in additional cohorts at a genome-wide
level of significance (p= 2.01 × 10−11, meta-analysis)58. Further-
more, rs941125 is significantly associated with variation in GLIS1
gene expression in several tissues in GTEx (https://gtexportal.org/
home/snp/rs941125). Together, these findings support a role for
GLIS1 in glaucoma pathogenesis in humans.
Discussion
In this study, we identify a critical role for the transcription factor
GLIS1 in the maintenance of TM/ocular drainage tissue, AqH
dynamics, and IOP. The TM is an essential component of the
ocular drainage structure and TM abnormalities play a major role
in the development of elevated IOP and glaucoma1,5,15,57,59,60.
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function causes a progressive degeneration of the TM leading to a
disruption of ocular drainage structures. As a consequence of
these changes, the AqH drainage is significantly compromised in
Glis1-KO eyes causing elevated IOP. In addition, we identified
several transcriptional targets of GLIS1 in TM cells that pre-
viously have been implicated in TM-related functions, IOP
homeostasis, and ocular hypertension/glaucoma, including
MYOC, ADAMTS10, LTBP2, LOXL1, TGFBR3, CYP1B1, and
EFEMP15,28,43,44. The reduced expression of a set of TM genes
together is likely responsible for the TM dysfunction and elevated
IOP in Glis1-KO mice. Importantly, we have detected significant
associations between common genetic variants in the GLIS1
region and POAG in humans, thereby supporting the role of
GLIS1 as a glaucoma risk gene. These variants may impact TM
functions and compromise AqH drainage by altering GLIS1
expression and/or function and leading to elevated IOP and
glaucoma.
The expression of Glis1 in the TM and the degeneration of the
TM in Glis1-KO mice suggested that GLIS1 plays a critical reg-
ulatory role in maintaining TM cell function and survival. It is
possible that GLIS1 deficiency leads to the disruption of a cell-
intrinsic biological process important in maintaining normal
structure and TM function. Excessive loss of TM cells has been
proposed to be a critical pathophysiological feature resulting in
defective AqH drainage and high IOP14. Although the pro-
nounced loss of TM cells in POAG patients was observed decades
ago13,61, much remains yet to be understood with regards to
cellular processes regulating the maintenance of the TM and
survival of TM cells and its relevance to IOP and the different
forms of glaucoma14,15,56. Various changes in the TM, including
alterations in ECM and mitochondria, increased oxidative stress,
and apoptosis, have been implicated in outflow resistance, ele-
vated IOP, and increased glaucoma risk15,41,42,55,62–65. Specifi-
cally, the ECM has been identified as a major player in
Fig. 4 Regulation of TM/glaucoma-related gene expression by GLIS1 in TM cells. a Volcano plots of genes downregulated (blue) and upregulated (red)
in HTM(shGLIS1) and Dox-treated HTM(pIND-GLIS1) and TM5(pIND-GLIS1) cells (as determined by DESeq2 at FDR 0.01). All other genes are in gray.
Several genes associated with IOP, glaucoma, or ECM are indicated (yellow diamonds). The x-axis represents gene expression log2-fold change (FC) and
the y-axis represents −log10 (p-value). b Heatmap of the differential expression of several TM-, glaucoma-, ECM-related mRNAs in HTM(shGLIS1), and
HTM(Scr) (Control) cells; underlying data are rlog-transformed quantification scores as reported by DESeq2 followed by row-scaling at FDR 0.01. Data
shown are for HTM (Scr), shGLIS1#1, and shGLIS1#5 replicates 1 and 2. c, d Heatmap of the differential expression of several TM-, glaucoma-, ECM-related
mRNAs in HTM(pIND-GLIS1) cells (c) expressing Dox-inducible Flag‐GLIS1‐HA treated for 18 h with or without Dox (Control) (n= 2) and TM5(pIND-
GLIS1) cells (n= 3) (d). e qPCR analysis of several genes downregulated in HTM(shGLIS1) compared to HTM(Scr) cells (n= 3, independent replicates).
f qPCR analysis (n= 3, independent replicates) of several genes induced by murine GLIS1 in TM5 cells expressing Dox-inducible Flag‐GLIS1‐HA. Cells were
treated for 18 h with or without Dox (±Dox). Data in e and f are represented as means ± SD. Statistical analyses were performed with a two-tailed Student’s
t test. p Values are shown above the bars.
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Fig. 5 GLIS1 regulates the transcription of a subset of TM/glaucoma-related genes in HTM cells through its interaction with GLISBS. a Heatmap and
ChIP-Seq read density plot showing GLIS1 occupancy in TM5(pIND-GLIS1) cells treated for 18 h with Dox (+Dox) compared to untreated cells (−Dox).
Each line in the heatmap represents an individual GLIS1 binding site. b Pie chart showing the location of GLIS3-binding peaks within specific regions of the
genome. TSS proximal: −1 kb to the transcription start site (TSS); upstream: −1 to −10 kb. c Homer de novo and known motif analysis identified GLIS-like
binding sites (GLISBS) as the top consensus sequence motif. Binding sites for transcription factors of the AP-1, FOX, and TEAD families were identified
alongside GLIS consensus motifs.
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Fig. 6 Genome browser tracks of the MYOC, CHI3L1, BMP2, FBN2, LOXL4, MMP2, LTBP2, COL6A2, CYP1B1, and ADAMTS10 genes (https://genome.
ucsc.edu/) showing GLIS1 occupancy (ChIP-Seq) in TM5(pIND-GLIS1) cells expressing Flag-GLIS1-HA. The AP-1, E-box, and NFκB binding sites in
MYOC and the AP-1 and G/C-rich SP1-binding sites in the CYP1B1 proximal promoter region are indicated.
Fig. 7 Regional plot at the GLIS1 genomic region showing association with glaucoma in the combined (GERA+UK Biobank) multiethnic meta-analysis.
Top SNP rs941125 is significantly associated with glaucoma after Bonferroni correction (p= 4.73 × 10−6).
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maintaining the structural integrity and functionality of the
TM55,59,61,64–66. Consistent with this, our gene profiling analyses
identified ECM-related processes, cytoskeleton, and cellular
adhesion as key pathways that are impacted as a consequence of
GLIS1 knockdown or ectopic expression of GLIS1 (Fig. 4e, f;
Supplementary Fig. 13). Moreover, several ECM-related genes,
which levels changed in TM cells upon GLIS1 knockdown or
overexpression, have previously been implicated in elevated IOP
and glaucoma, including members of the collagen I, IV, and VI
families, LTBP2, a regulator of TGFβ signaling and ECM
deposition28,67. Furthermore, the expression of a number of
microfibril-associated genes is also impacted, including FBN2,
encoding a microfibril-associated glycoprotein that contributes to
elastin assembly in the ECM of the TM60,68. It further includes
LOXL1–4, encoding lysyl oxidases that mediate the cross-linking
of several ECM proteins, such as collagens and elastin21,69, and
ADAMTS10, encoding a metalloproteinase involved in ECM
assembly44,70. Alterations in the expression of these genes are
likely to impact ECM assembly as well as its biomechanical
properties, and physiological processes, such as differentiation,
survival, and tissue organization that are regulated by the ECM-
dependent signaling pathways71. Thus, altered cell-ECM inter-
action or abnormal ECM organization in Glis1-KO mice might
adversely affect the maintenance and biomechanical properties of
the TM, thereby leading to progressive degeneration of the TM
and disruption of the AqH drainage and subsequently to the
development of elevated IOP and glaucoma14,42,62,63. Given a role
for ECM-dependent pathways, it is possible that change in bio-
mechanical properties of the TM (TM stiffness) may contribute to
IOP changes, especially during an early time window prior to any
obvious structural changes not captured by histological
assessment.
In addition to these ECM and adhesion-related genes, tran-
scriptome analysis showed that GLIS1 impacts the expression of
several other TM-, IOP-, and glaucoma-related genes, including
MYOC and CYP1B1 (Fig. 4a, e, f; Supplementary Fig. 12). It is
interesting to note that the phenotypic changes in the TM
observed in Glis1-KO mice exhibit some resemblance with those
seen in Cyp1b1-deficient mice, including the collapse and
degeneration of the TM37,61. Thus, the reduced CYP1B1 expres-
sion might contribute to the structural changes in the TM and
elevated IOP observed in Glis1-KO mice. In the case of MYOC,
mutations in MYOC are thought to act by a gain of function
mechanism resulting in the misfolding and accumulation of
mutant MYOC leading to ER stress and apoptosis of TM
cells72,73. Moreover, studies with Myoc knockout mice suggest
that loss of Myoc function by itself does not cause ocular drainage
tissue abnormalities or IOP elevation74. These studies indicate
that reduced expression of Myoc observed in Glis1-KO mice is
unlikely by itself inducing TM abnormalities and elevated IOP.
We hypothesize that reduced expression of a set of genes rather
than one particular single gene is causing the TM abnormalities
and high IOP in GLIS1 deficiency, as we reported for the
development of congenital hypothyroidism and neonatal diabetes
in Glis3-KO mice32,47. Thus, the altered expression of a set of
TM genes, including CYP1B1, ADAMTS10, and LTBP2, may
underlie TM dysfunction and elevated IOP. Therefore, the effect
of Glis1 deficiency on mouse TM is likely a cumulative effect of
disruption of multiple pathways.
To establish which of the differentially expressed genes were
directly regulated by GLIS1, we performed a ChIP-Seq analysis.
This analysis revealed that GLIS1 binding was associated with
MYOC, ADAMTS10, CYP1B1, MMP2, and many other genes,
suggesting that these genes are direct transcriptional targets of
GLIS1 (Supplementary Table 2). Interestingly, many of the direct
targets of GLIS1 have a role in the ECM or TM function and have
been implicated in the pathogenesis of elevated IOP and
glaucoma6,28,44,56. Homer motif analysis suggested co-
localization of GLIS1 binding peaks with motifs of other tran-
scription factors, including binding sites for members of the
AP-1, TEAD, and forkhead box (FOX) families (Fig. 5). Inter-
estingly, the proximal promoters of MYOC and CYP1B1 have
been reported to contain functional binding sites for AP1-related
transcription factors near the location of the GLIS1 binding peaks
(Fig. 6)52–54,75,76. The forkhead box member, FOXC1, has been
implicated in the regulation of TM functions and glaucoma77,78,
while the Hippo pathway through activation of TEAD tran-
scription factors regulates ECM in TM cells and appears to have a
role in glaucoma50,51,79. Together, these observations support a
model in which a selective set of GLIS1 target genes are co-
regulated with other transcription factors through their interac-
tion within the same regulatory regions in TM-specific genes.
Our genetic studies provide further validation for the role of
GLIS1 in glaucoma pathogenesis and extend our findings in mice
to humans. The observed ocular drainage defects exhibited by
Glis1-KO mice are more severe than those observed in POAG and
likely due to a complete deficiency of GLIS1 and the suppression
of many target genes, as compared to TM-specific changes ori-
ginating from potential gene dosage effects of POAG-associated
variants. The lead SNP rs941125 is not only associated with
glaucoma in multiple independent cohorts58, it is also detected as
an eQTL associated with a change in GLIS1 expression (https://
gtexportal.org/home/snp/rs941125). We note, however, that
GTEx does not contain information on eye tissues and that the
eQTL analysis for rs941125 is based on expression data from
brain tissue. Future studies need to determine whether rs941125
or other SNPs in linkage disequilibrium with rs941125 are located
within gene regulatory elements (such as enhancers) that affect
GLIS1 expression and how alteration of these regulatory elements
predispose the eyes to TM dysfunction leading to IOP elevation.
Since POAG is multifactorial, it is likely that variants in other
genes together with GLIS1 SNPs may cooperate to induce high
IOP in patients. The absence of such other modifier alleles in
Glis1 heterozygous mice might explain why the presence of a
single knockout allele of Glis1 is not sufficient to induce ocular
drainage defects leading to elevated IOP.
In this study, we identify a critical role for GLIS1 in the
maintenance and regulation of TM function, AqH dynamics, and
IOP. GLIS1 together with other transcription factors might be
part of a regulatory network required for proper maintenance and
functioning of ocular drainage tissue and IOP homeostasis45.
Thus, Glis1-KO mice provide us with a valuable model to uncover
cellular and molecular mechanisms that underlie the regulation of
TM maintenance and ocular drainage tissue homeostasis and
potentially lead to new insights into the pathogenesis of glau-
coma. In addition, our data further suggest that altered expression
of GLIS1 in individuals carrying the risk allele may confer
increased susceptibility toward developing POAG possibly by
impacting the TM and thereby contributing to elevated IOP.
Finally, as has been shown for the hedgehog/GLI signaling
pathway, regulation of GLIS proteins25 by primary cilium-
associated G protein-coupled receptors might be useful for the
development of new therapeutic strategies in the management of
various pathologies, including glaucoma.
Methods
Glis1-deficient mice. Glis1-deficient mice (Glis1-KO) were described previously30.
Mice were bred into the C57BL/6NCrl Charles River, Wilmington, MA) and
129S6/SvEvTac (Taconic, Rensselaer, NY) backgrounds for at least seven genera-
tions. We ensured that mice maintained in C57BL/6NCrl neither carried homo-
zygous RD8 mutation nor exhibited retinal degeneration (based on an ocular
histological assessment). Glis1-KO mice on both backgrounds developed enlarged
eyes and appeared to exhibit a similar phenotype. Most experiments were carried
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out with Glis1-KO C57BL/6NCrl mice. Mice were supplied ad libitum with auto-
claved NIH-31 rodent diet (Harlan Laboratories, Madison, WI) and provided with
distilled drinking water and were group-housed in individually ventilated cages
(Techniplast, Exton, PA). Experiments took place in an AAALAC accredited
facility maintained at 70–73 °F, relative humidity 40–60%, and 12 h:12 h light–dark
cycle. All mice were negative for rodent murine pathogens. Littermate wild-type
(WT) mice were used as controls. All animal protocols followed the guidelines
outlined by the NIH Guide for the Care and Use of Laboratory Animals and were
approved by the Institutional Animal Care and Use Committee at the NIEHS.
Routine genotyping was carried out with the following primers: Glis1-F, 5′-
AGCTAGTGGCTTTCGCCAACA; Glis1-R, 5′-GAACAAGATAGAATCATGG-
TATATCC and Neo-pro, 5′-ACGCGTCACCTTAATATGCG.
T3, T4, and thyroid-stimulating hormone (TSH) assays. Blood levels of T3 and
T4 were measured by radioimmunoassay (MP Biomedicals, Orangeburg, NY) as
described previously32. Serum TSH was analyzed with a mouse pituitary magnetic
bead panel kit (EMD Millipore Corp., Billerica, MA.
RNAscope in situ hybridization. In situ hybridization was carried out on
formalin-fixed paraffin-embedded tissue sections using the RNAScope system
(Advanced Cell Diagnostic, Hayward, CA) per manufacturer’s instructions and as
previously described80.
IOP measurement. IOP of both eyes in age- and gender-matched WT and Glis1-
KO littermates was measured using the Icare TonoLab rebound tonometer (Icare,
Helsinki, Finland). Immediately prior to measurement animals were briefly sedated
using isoflurane. IOP was measured at least 4 times/eye within a 30 min time frame
with each individual IOP recorded representing the average of six measurements,
giving a total of 24 rebounds from the same eye.
Ocular angle assessment. Hematoxylin and eosin-stained ocular sections cut
from plastic embedded eyes were assessed to examine the morphology of the ocular
angle structures. Briefly, mice were euthanized and eyes enucleated and immedi-
ately immersed in cold fixative (1% PFA, 2% glutaraldehyde, and 0.1 M cacodylate
buffer) for at least 48 h, after which they were transferred to cold 0.1 M cacodylate
buffer solution and stored at 4 °C. We have found that using this fixative, greatly
improves capturing the SC in its intact/non-collapsed conformation. For example,
at around 3 months of age 100% of WT eyes showed intact SC. Samples were
embedded in glycol methacrylate, and serial sagittal sections (2 μm) passing
through the optic nerve were cut and stained with hematoxylin and eosin (H&E).
Ten similarly spaced sections corresponding to the peripheral, mid-peripheral, and
central regions (passing through the optic nerve) of the eye were evaluated81. Both
angles of a section were considered for evaluation. The prominent angle-relevant
structures, including TM, SC, Iris, ciliary processes were histologically examined. A
representative image showing angle-relevant tissues is indicated in Supplementary
Fig. 14. Eyes assessed for each of genotype included both sexes.
The sections corresponding to the central region of the eye were used for
measuring the TM area, which in our experience provides the most reliable
assessment. We imaged on average five consecutive serial sections per eye from
both wild type and Glis1- KO mice. Cross-section images were taken using a 20×
objective on the Zeiss Axiophot microscope with a 12 Mp Insight camera. TM
images were captured by SPOT5.6 imaging software, assigned an accurate 20×
calibration (to account for the magnification of the acquired image), and the TM
area (marked in Supplementary Figs. 5 and 6) was measured using the “region” tool
under the EDIT menu. The mean TM area was calculated from a minimum of five
central ocular sections/eye.
Assessment of the SC. Briefly, the anterior segment is excised and the iris
removed. The anterior segment cup is relaxed by making four centripetal cuts.
These cuts generated four fan-shaped quadrants attached at the center. The SC
runs along the rim (limbus) of each fan-shaped quadrant. Whole mounts of the
anterior segments from control and Glis1-KO mice were stained with an endo-
mucin antibody82. Briefly, the anterior segment is excised and the iris removed.
The anterior segment cup is relaxed by making four centripetal cuts. These cuts
generated four fan-shaped quadrants attached at the center. The SC runs along the
rim (limbus) of each fan-shaped quadrant. The anterior segment was stained with
endomucin (5 µg/ml; Thermo Fisher Scientific), the whole mounted, and the entire
limbus encompassing each of the four quadrants imaged using a Leica LSM SP8
confocal system and DM6000 vertical microscope. The limbal region was imaged
with a 20×/0.75 IMM CORR CS2-multi-immersion objective using glycerol
immersion media. Overlapping regions (10%) were collected as Z-stacks at a
resolution of 541 × 541 × 1 µm. The overlapping Z-stack of a quadrant was stitched
using XuvStitch freeware83. The confocal Z-stack of the stitched quadrants of the
limbus was rendered in three dimensions using the Surpass mode of Imaris 9.2
(Bitplane). Imaris Surface tool was used to render a surface onto the endomucin
labeled SC. The volume was obtained from the “Statistic” tab under the surface
algorithms in the software. The data was downloaded as a.csv file. The volumes of
SC in quadrats were graphed using PlotsOfData-A web app for visualizing data
together with their summaries84.
AqH dynamics by Gadolinium magnetic resonance imaging (Gd MRI). AqH
dynamics were analyzed by 3D Gd MRI as described34,35. The MR imaging data are
accessible via the following url: https://civmvoxport.vm.duke.edu/voxbase/
studyhome.php?studyid=733. All MRI measurements were performed utilizing a
7.1-Tesla/22-cm horizontal bore Magnex magnet with an Agilent Direct Drive
Console (Santa Clara, CA, USA), providing up to 770 mT/m gradient strength, and
a 35 mm transmit–receive birdcage coil. Mice (n= 5) were anesthetized with iso-
flurane (2% for induction and 1.5% for maintenance) and kept warm with warm
circulating air during the MRI experiment. Respiration rate was monitored using a
small pneumatic pillow (SA Instruments, Inc., Stony Brook, NY, USA).
Gadolinium-DTPA (Magnevist, Schering, Germany) was intraperitoneally (i.p.)
injected at a dose of 0.3 mmol/kg after one T1-weighted MR image was acquired at
baseline. The MR contrast was thus administered at a dose calculated to normalize
the body mass for each animal.
Some mice were treated with the IOP lowering compound Ripasudil (0.4%
normal isotonic saline; Sigma), which was administered in 5 μl drops to the right
eye, while normal isotonic saline was added to the left eye. T1-weighted MR images
were acquired using a gradient echo sequence repeated over 2 h, sampling at 10m
intervals, for a total of 12 scans. The imaging parameters were repetition time/echo
time= 200/1.92 ms, the field of view= 14.4 × 14.4 mm2, matrix 192x192, flip angle
20 degrees, BW 62.5 kHz, and the in-plane resolution was 75 × 75 μm2. 11 coronal
slices, 0.38 mm thick were acquired. 16 averages were used for each scan, resulting
in a total scan time for each temporal sampling interval of 10min 12 s. An
additional scan was acquired at the end of the dynamic contrast-enhanced study,
using identical parameters but increasing the number of averages to 64, to help
delineate the anatomy. Select specimens were imaged ex vivo using a multi gradient-
echo sequence. Eye specimens were prepared after trans cardiac perfusion fixed with
a mixture of saline and ProHance (10%), followed by a mixture of formalin and
ProHance (10%). The imaging parameters were repetition time/echo time= 50/3
ms, the field of view= 25.6 × 12.8 × 12.8mm2, matrix 512 × 256 × 256, flip angle
60°, BW 62.5 kHz, and the 3D isotropic resolution was 50 μm× 50 μm× 50 μm.
Regions of interest (ROIs) were manually drawn in the T1-weighted imaging
slice bisecting the center of the globes, using ImageJ v1.47 (Wayne Rasband,
National Institutes of Health, Bethesda, MD, USA). We measured the enhancement
of the signal intensity (brightness of voxels) due to Gd accumulation in the AC, and
our measurements were averaged over the entire ROIs. To compensate for inter
animal variability and to reflect the relative enhancement in each animal, these
measurements were normalized to the 10 min baseline. Several studies have
demonstrated a linear relationship between the concentration of Gd and the spin-
lattice relaxation rate (R1= 1/T1) over limited ranges of concentration85–87.
MØrkenborg et al.88 have performed experiments at 7 T, the field used in these
studies, and demonstrated a linear correlation (r2 > 0.92) between signal intensity
in a gradient echo for concentrations ranging between 0 and 3.0 mmol/lGd-DTPA.
Thus, while concentration was not measured directly by the measurement of R1, it
can be inferred from the signal intensity. In addition, we have a curve
normalization to the same time (10 min) acquired in each animal to adjust for
different gains. The averaged time course from each ROI measurement before and
after Gd injection was fitted into a sixth-degree polynomial using MatLab2016a
(The MathWorks, Inc., Natick, MA, USA). The peak percentage (%) Gd signal
enhancement, time to peak, the initial rate of Gd signal increase within the first
10 m after Gd injection, and the area under the curve was extracted from the time
courses and compared between both eyes of the same groups using two-tailed
paired t tests, and across groups using one-way ANOVA and post hoc Tukey’s
tests. Data are presented as mean ± standard deviation unless otherwise specified.
Results were considered significant when p < 0.05.
Cell lines. Human kidney HEK-293T cells were obtained from ATCC and grown
in DMEM plus 10% fetal bovine serum (FBS). Primary HTM cells were provided
by Dr. T. Borras. Cells were grown in Modified IMEM (Cat. No. A1048901)
supplemented with 10% FBS (Gibco, Grand Island, NY) and 50 μg/ml gentamycin
(ThermoFisher) and used at <3 passages. Immortalized HTM-like HTM5 cells
(TM5)90 were cultured in DMEM/F12 supplemented with 10% FBS, L-glutamine,
penicillin (100 units/ml), streptomycin (0.1 mg/ml), and amphotericin B (4 mg/ml).
Cells were tested negative for mycoplasma at NIEHS or UCSF.
Reporter assay. HEK-293T cells were transfected in Opti-MEM with pTAL-Luc-
(GLISBS)6 reporter, in which the luciferase reporter is under the control of six
copies of GLISBS, pCMV-β-Gal, and a pCMV10 expression plasmid containing
wild type Flag-GLIS1 or a Flag-GLIS1 mutant using Lipofectamine 2000. Twenty-
four-hour later cells were harvested into 125 μl reporter lysis buffer and luciferase
activity and β-galactosidase levels were measured using a luciferase assay kit
(Promega, Madison, WI) and a luminometric β-galactosidase detection kit (Takara
Bio, Palo Alto, CA) following the manufacturer’s protocol. Experiments were
carried out in independent triplicates89.
GLIS1 shRNA knockdown. GLIS1 knockdown in HTM cells was performed
by infecting cells with GLIS1 shRNA lentivirus (Dharmacon; GLIS1#1-
TRCN0000107705 and GLIS1#5-TRCN0000107709 or scrambled shRNA (control)
(MOI 1:10). These cells are referred to as HTM(shGLIS1) and HTM(Scr). Forty-eight
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hours later cells were collected and RNA isolated with a Purelink RNA mini kit
(ThermoFisher Sci., Rockford, IL) for RNA-Seq analysis as described32,46.
Quantitative-PCR. Kidney, ciliary body, TM, cornea, and retina were dissected
from eyes of 3-month-old WT mice (n= 3), RNA was isolated using a RNeasy
mini kit (Qiagen) and reverse-transcribed using the High-Capacity cDNA Archive
Kit (Applied Biosystems, Foster City, CA). Glis1 expression was then measured by
digital droplet PCR (ddPCR) using the QX200™ Droplet Digital™ PCR System
(BioRad) and normalized to Hsp90a01 expression. Primers for Glis1 (Mouse;
PrimePCR ddPCR Expression Probe Assay (BioRad); FAM; dMmuCPE5121630)
and Hsp90ab1 (Mouse; PrimePCR ddPCR Expression Probe Assay (BioRad); HEX;
dMmuCPE5097465). Accepted ddPCR reads had a minimum of 12,000 events and
cDNA concentrations were adjusted to be within 10–10,000 positive events. To
analyze gene expression from cultured cells, QPCR analysis was performed using
SYBR Green I (Applied Biosystems, Foster City, CA). RNA from cultured HTM
and TM5 cells was isolated with a Purelink RNA mini Kit (ThermoFisher) and
QPCR analysis was performed as described previously32,46. RNAs from human
tissues were from a Clontech Human Total RNA Master Panel II (#636643). Pri-
mer sequences are listed in Supplementary Table 1.
ChIP-Seq analysis with Flag-GLIS1‐HA HTM and TM5 cells. Since no suitable
GLIS1 antibody is available for ChIP-Seq analysis, we used primary HTM cells
transiently expressing doxycycline (Dox)-inducible Flag‐GLIS1‐HA and a TM-like
cell line, TM5, that stably expressed Dox-inducible Flag-GLIS1-HA. First, a pIND20
(Flag‐GLIS1‐HA) plasmid was generated by inserting Flag‐GLIS1‐HA into the
(Dox)-inducible lentiviral expression vector pIND2091 and are referred to as HTM
(pIND-GLIS1) and TM5(pIND-GLIS1), respectively. Lentivirus was generated by
transient transfection of pIND20(Flag‐GLIS3‐HA) in HEK293T cells together with
psPAX2 and pMD2.G plasmids. TM5 cells were infected with the pIND20(Flag‐
GLIS1‐HA) lentivirus for 48 h and then selected in a medium supplemented with
750 μg/ml G418 (Invitrogen, Carlsbad, CA). Flag‐GLIS1‐HA expression was
induced by the addition of 300 μg/ml Dox (Sigma–Aldrich, St. Louis, MO). The
expression of Flag-GLIS1-HA protein was examined by immunofluorescence. The
relative fluorescent signal in nuclei was determined using ImageJ software (Fuji) as
described92. To identify genes directly regulated by GLIS1, ChIP-Seq analysis was
performed using TM5 cells stably expressing doxycycline (Dox)-inducible GLIS1-
HA. ChIP analysis was performed as described previously32,46. Cells were treated
with and without Dox for 18 h and crosslinked with 1% formaldehyde in PBS for
10min at RT and then quenched by glycine (final 125mM) for 10min at RT. Cells
were washed two times with PBS and then sonicated for 40min (S220 focused-
ultrasonicator, Covaris, Woburn, MA). After removal of cell debris, chromatin was
incubated overnight with HA antibody (Cell Signaling, #3724) and subsequently,
incubated with Dynabeads Protein G (ThermoFisher Scientific, 10004D) for 3 h at
4oC to pulldown GLIS1-HA-chromatin complexes. The chromatin-bound beads
were then washed and reverse cross-linked. Libraries were made with the ChIPed-
DNA using Nextflex ChIP-Seq Library Prep kit (PerkinElmer). Sequencing reading
was performed with a NovaSeq 6000 system (Illumina). TM5(-Dox) cells served as a
negative control to determine specificity93. UCSC Genome Browser Human Feb.
2009 (GRCh37/hg19) Assembly was used to generate the genome browser tracks.
ChIP-seq analysis. ChIP-seq data were generated as single-end reads with a
NovaSeq 6000 (Illumina). Raw sequence reads were filtered to remove any entries
with a mean base quality score < 20. Adapters were removed via Cutadapt v1.12
with parameters “-a AGATCGGAAGAG -O 5 -q 0”, then reads were filtered to
exclude those with length <30 bp after trimming. Filtered and trimmed reads were
mapped against the hg19 reference assembly (excluding haplotype chromosomes)
via Bowtie v1.2, with only uniquely mapped hits accepted. Duplicate mapped reads
were removed by Picard tools MarkDuplicates.jar (v1.110). Initial peak calls were
made with HOMER (v4.10.3) with parameters “-style factor -fdr 0.00001”, com-
paring each ChIP sample (Dox+ or Dox−) against its associated input sample. The
Dox+ peak set was then filtered to exclude any peak that (a) overlapped a Dox-
peak, (b) has fold change over input <8× (as reported by HOMER), or (c) has fold
change over local signal <8x (as reported by HOMER). The Dox+ peaks were re-
sized to 200 bp centered on the called peak midpoints prior to downstream ana-
lysis. Enriched motifs were identified by HOMER ‘findMotifsGenome’ at “-size is
given” and all other parameters default. Coverage tracks for genome browser views
were generated by extending each uniquely mapped non-duplicate read to the
estimated average fragment size of 150 bp, depth normalizing to 25M reads, then
converting to bedGraph format with BEDtools v2.24.0 genomeCoverageBed and
subsequently to bigwig format with UCSC utility bedGraphToBigWig v4.
RNA-seq analysis. RNA-seq data was generated as paired-end reads with a NextSeq
5000 (Illumina). Raw sequence reads were filtered to remove any entries with a mean
base quality score < 20 for either end in the pair. Filtered reads were then mapped to
the hg19 reference assembly (excluding haplotype chromosomes) via STAR v2.5 with
parameters “–outSAMattrIHstart 0–outFilterType BySJout–alignSJoverhangMin
8–limitBAMsortRAM 55000000000–outSAMstrandField intronMotif–out-
FilterIntronMotifs RemoveNoncanonical”. Counts per gene were determined via
featureCounts (Subread v1.5.0-p1) with parameters “-s0 -Sfr” for Gencode V28 gene
models. Differential analysis was performed with DESeq2 v1.14.1.
Pathway analysis. Pathway analysis was performed via DAVID tools (v6.8) for
KEGG pathway analysis94,95.
Immunostaining. Expression of GLIS1-βGAL fusion protein was examined by
staining tissue sections with chicken anti-βGAL (1:500, ab9361, Abcam) and Alexa
Fluor@ 488 donkey anti-chicken IgG (1:2000, A11039, Invitrogen) as described
previously96. Expression of Anti-HA fusion protein was examined by staining cells
with rabbit Anti-HA (1:250; #3724, Cell Signaling Technology) and Alexa Fluor@
488 donkey anti-rabbit IgG (1:2000, A21208, Invitrogen). Fluorescence was
observed in a Zeiss LSM 710 confocal microscope.
Genetic association analyses. To determine the association of genetic variants in
the GLIS1 region with glaucoma, we utilized the Genetic Epidemiology Research in
Adult Health and Aging (GERA) cohort comprising of 4986 POAG cases and
58,426 controls and a multiethnic UK Biobank (UKB; https://www.ukbiobank.ac.
uk/) cohort consisting of 7329 glaucomas (subtype unspecified) cases and 169,561
controls from five ethnic groups (European, East Asian, South Asian, African
British, and mixed ancestries. The GERA cohort consists of 110,266 adult men and
women, 18 years and older, who are of non-Hispanic white, Hispanic/Latino,
Asian, or African American ethnicity. Participants from the GERA cohort are
members of the Kaiser Permanente Northern California (KPNC) integrated health
care delivery system and provided self-reported information via the Research
Program on Genes, Environment, and Health (RPGEH) survey. The UKB is a large
prospective study following the health of approximately 500,000 participants from
5 ethnic groups (European, East Asian, South Asian, African British, and mixed
ancestries) in the UK aged between the ages of 40 and 69. For UKB participants,
demographic information and medical history were ascertained through touch-
screen questionnaires. UKB participants also underwent a wide range of physical
and cognitive assessments, including blood sampling. GERA individuals’ DNA
samples were extracted using Oragene kits (DNA Genotek Inc., Ottawa, ON,
Canada) at KPNC and genotyped at the Genomics Core Facility of UCSF. DNA
samples were genotyped at over 665,000 genetic markers on four race/ethnicity-
specific Affymetrix Axiom arrays (Affymetrix, Santa Clara, CA, USA) optimized
for European, Latino, East Asian, and African–American individuals. We per-
formed genotype quality control (QC) procedures for the GERA samples on an
array-wise basis. Briefly, we included genetic markers with an initial genotyping call
rate ≥ 97%, genotype concordance rate > 0.75 across duplicate samples, and allele
frequency difference ≤ 0.15 between females and males for autosomal markers.
Approximately, 94% of samples and over 98% of genetic markers assayed reached
QC procedures. Moreover, genetic markers with genotype call rates < 90% were
excluded, as well as genetic markers with a MAF < 1%. We also performed
imputation on an array-wise basis. Following the paraphrasing of genotypes with
Shape-IT v2.r7271959, we imputed genetic markers from the cosmopolitan 1000
Genomes Project reference panel (phase I integrated release; http://1000genomes.
org) using IMPUTE2 v2.3.060. We used the information r2 from IMPUTE2 as a
QC parameter, which is an estimate of the correlation of the imputed genotype to
the true genotype9,22,97. GLIS1 gene locus was defined as ±500 kb upstream and
downstream of the sequence using UCSC Genome Browser Assembly February
2009 (GRCh37/hg19). PLINK v1.9 was used to perform a logistic regression of the
outcome and each SNP. Other statistical analyses and data management were
performed in the language-and-environment R, version 3.6.0, using functions from
the default libraries. All study procedures were approved by the KPNC Institutional
Review Board and the protocols followed are compliant with specific Ethical
Regulations. Written informed consent was obtained from all participants. The
GLIS1 variant-level associations with glaucoma are fully disclosed in the manu-
script (Supplementary Data 1 “Association of GLIS1 SNPs with POAG in the
multiethnic meta-analysis (GERA+UKB)”). The meta-analysis GWAS summary
statistics of glaucoma are available from the NHGRI-EBI GWAS Catalog study
https://www.ebi.ac.uk/gwas/search?query=GCST006065.
Statistical analysis. Data are presented as mean ± standard deviation and were
analyzed using a two-tailed Student’s t test using Microsoft Excel and/or Prism 8.4
(GraphPad). To identify genetic variants in GLIS1 associated with glaucoma, we
performed logistic regression analysis adjusted for age, sex, and ancestry principal
components.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source data for Figures [Figs. 1–4 and Supplementary Figs. 1, 2, 5–7, 10–12] are provided
with the paper.
The ChIP-seq and RNA-seq data described in this manuscript have been deposited in
the NCBI Gene Expression Omnibus (GEO) with accession GSE156846.
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The meta-analysis GWAS summary statistics of glaucoma are available from the
NHGRI-EBI GWAS Catalog (https://www.ebi.ac.uk/gwas/downloads/summary-
statistics), study accession number GCST006065.
The MR imaging data will be accessible after registration at the following URL (a
password will be issued the following day that will provide access): https://civmvoxport.
vm.duke.edu/voxbase/studyhome.php?studyid=733. Source data are provided with
this paper.
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